Clinical Trial Update: Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and potential therapeutic effects of umbilical cord blood regulatory T cells for Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Umbilical cord blood Treg

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Diabetes Mellitus, Type 1 | Phase 1, Phase 2 | Status: UNKNOWN